Morus and Curcumin Composition for Bone Density
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for osteoporosis and bone disorders, such as NSAIDs and COX-2 inhibitors, have limitations in effectively managing bone density and cartilage health, particularly in post-menopausal women, and there is a need for alternative compositions that can enhance bone and cartilage integrity without adverse effects.
Innovation Solution
A composition comprising a mixture of Morus extract enriched for prenylated flavonoids, stilbenes, and optionally other bioactive compounds like calcium, vitamin D, and glucosamine, combined with Acacia or Uncaria extracts, which work synergistically to promote bone and cartilage health by inhibiting harmful enzymes and enhancing density.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If NSAIDs and COX-2 inhibitors are used to manage bone density, then bone loss is reduced, but cartilage health deteriorates and adverse effects occur
Solution Approach 1:
The patent converts the harmful inflammatory response into a beneficial healing mechanism by using curcumin to modulate cytokine production. Curcumin inhibits pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) that cause bone loss while simultaneously promoting anti-inflammatory cytokines that support cartilage repair and bone formation, thus transforming the harmful inflammatory pathway into a beneficial healing process.
Solution Approach 2:
The patent changes the biochemical parameters of the inflammatory response by introducing curcumin, which shifts the balance from pro-inflammatory to anti-inflammatory cytokines. This parameter change in cytokine production profiles allows the system to achieve both bone density preservation and cartilage protection, resolving the contradiction between these two functions.
2Reliability
If COX-2 selective NSAIDs are used to protect bone loss, then bone mineral density is maintained, but joint pain and stiffness increase
Solution Approach 1:
The patent converts the harmful effect of COX-2 inhibition (increased joint pain and stiffness) into a benefit by using curcumin to modulate the inflammatory pathway. Curcumin inhibits COX-2 and LOX enzymes while simultaneously reducing pro-inflammatory cytokines, thereby reducing joint pain and stiffness without compromising bone density protection.
Solution Approach 2:
The patent uses a composite approach by combining curcumin with other bioactive compounds (resveratrol, quercetin, kaempferol) to create a synergistic formulation. This composite composition provides multiple mechanisms of action: COX-2 inhibition, LOX inhibition, and cytokine modulation, thereby achieving both bone density maintenance and joint comfort improvement.
3Productivity
If inflammatory cytokines are elevated to manage bone turnover, then bone reabsorption increases, but bone formation is impaired
Solution Approach 1:
The patent changes the parameter of cytokine balance by introducing curcumin, which shifts the ratio from pro-inflammatory to anti-inflammatory cytokines. This parameter change in cytokine production allows the system to maintain appropriate bone turnover while preserving bone formation capacity, resolving the contradiction between these two opposing functions.
Data Source
AI summary
The present disclosure provides mixtures of prenylated flavonoids, stilbenes, or both with flavans or curcuminoids or both capable of useful for promoting, managing or improving bone health, cartilage health or both, or for preventing or treating a bone disorder, cartilage disorder or both. Such a mixture of prenylated flavonoids, stilbenes, or both with flavans or curcuminoids or both can optionally be used in combination with other bone and cartilage management agents, such as calcium, magnesium, zinc, boron, vitamin D, vitamin K, glucosamine and/or chondroitin compounds, non-steroidal anti-inflammatory agents/analgesics, COX/LOX inhibiting agents, neuropathic pain relief agents, or the like.